FDC Ltd (FDC) is currently trading at 378.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

FDC Limited is a fully integrated, research-oriented pharmaceutical company manufacturing and marketing Finished Dosage Formulations and Active Pharmaceutical Ingredients (APIs), with legacy brands in ORS, ophthalmics, anti-infectives and nutraceuticals and manufacturing facilities across Roha, Waluj, Sinnar, Verna (Goa) and Baddi. Q2 FY26 consolidated revenue declined to Rs. 473 crore (-7.9% YoY) and H1 FY26 revenue was Rs. 1,121 crore (-2.7% YoY); EBITDA fell sharply to Rs. 35 crore (7.5% margin) due to strategic increases in R&D and field-force costs while exports and API segments partially offset domestic weakness. Domestic Formulations remain the revenue engine, contributing ~80% of quarterly sales, but showed notable softness (Domestic Formulations Q2 down 10.7% YoY); conversely API sales and non-US exports rose, and the US ophthalmic business showed signs of recovery after prior partner-related setbacks. Regulated-market validations continued: FDC secured USFDA approvals for Olopatadine 0.2% and Moxifloxacin 0.5% ophthalmic solutions, strengthening its ophthalmic export pipeline and validating its capability to commercialize regulated-market ANDAs while also maintaining multiple DMFs, CEPs and global certifications.

Over the past 52 weeks, FDC Ltd has traded between a low of ₹314.75 and a high of ₹473.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

FDC Ltd has a market capitalization of approximately 6,140.38. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

FDC Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.60 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 6,140.38 Cr, FDC Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

FDC Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of FDC Ltd is 19.60. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Yes. FDC said all promoter and promoter-group entities informed it on October 27, 2026 that they intend to participate. They plan to tender their pro rata entitlement based on holdings on the November 13, 2026 record date.

FDC is offering Rs 500 for each equity share accepted in its tender buyback. The offer covers up to 24 lakh shares for a maximum Rs 120 crore, excluding transaction costs.

FDC has set Friday, November 13, 2026, as the record date for its share buyback. Shareholders holding FDC shares in their demat accounts on that date are eligible to participate, subject to the offer terms.

FDC reported Q2 revenue from operations of ₹572 crore.